Navigation Links
OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer
Date:2/19/2013

delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward looking statements which speak only as of the date they are made. OncoSec Medical disclaims any obligation to update any forward looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
2. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
3. OncoSec Medical Announces $7.2 Million Public Offering
4. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
5. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
6. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
7. OncoSec to Present at Upcoming Healthcare and Investor Conferences
8. OncoSec Granted New Patent from China
9. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
10. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
11. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... and TORONTO , May 22, 2013 /PRNewswire/ ... John Mon , Chief Operating Officer, will ... Thursday, May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 4:00 p.m. ... access the webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   ...
(Date:5/22/2013)... May 22, 2013  BD (Becton, Dickinson and Company) ... technology company, announced today the publication of its ... Report and it continues to focus on the Company,s ... believe the principles of shared value — creating value ... of societies — are fundamental to our strategy," said ...
(Date:5/22/2013)... , May 22, 2013 Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for its Phase ... TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular ... date the trial has had no Severe Adverse Effect (SAE) ... therapy for HCC, registered with NIH under number NCT01828762 ...
Breaking Medicine Technology:Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Market Outlook to 2017 - Ultrasound ... Nuclear Imaging Equipment, X-Ray Systems, Mammography ...
... Spain, December 14, 2011 The Contract ... the pharmaceutical, fine chemicals, biotechnological, veterinary, cosmetic and nutraceuticals ... group Ipsen to take in a team of eight ... Llobregat (Barcelona). For Kymos -with headquarters in ...
Cached Medicine Technology:Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 2Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 3Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 4Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 5Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 6Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 7Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 8Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 9Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 10Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 11Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 12Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 13Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 14Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 15Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen 2
(Date:5/22/2013)... 2013 In partnership with the ... LLC, E-Dentists.com has launched a new SEO blog ... numerous topics of interest to dentists and their ... health. , http://www.E-Dentists.com/Blog/ , Blogging has ... In addition to addressing keyword placement and link ...
(Date:5/22/2013)... Women,s Hospital (BWH) finds that a genetic risk factor ... may be effective in identifying individuals at risk for ... the American Thoracic Society International Conference and publish online ... on May 22 and will appear in the ... the MUC5B gene is fairly common, pulmonary fibrosis is ...
(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
(Date:5/22/2013)... CO and Purchase, NY (PRWEB) May 22, 2013 ... has formed an exclusive partnership with Aurora ... an innovative marketing tool to companies that offer ... health card rewards members for completing 3 out ... The healthcare incentive product launched March 2013, and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 In the ... the country’s fields and courts with donated uniforms, ... a Massachusetts-based nonprofit dedicated to partnering with manufacturers to ... celebrating the donation of $8.8 million in sports and ... than a half-million kids outfitted for physical activity. ...
Breaking Medicine News(10 mins):Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Integrated Printing Solutions and Aurora Financial Systems, Inc. Create Partnership for Healthcare Incentive Card 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3
... for Nurses are given as a mark of highest recognition ... profession in the country. ,Till the year 1989, ... Nurse Midwives and 3 for Lady Health Visitors). ... of highest recognition for the meritorious services of the nurses ...
... 30th Annual Scientific Sessions of the Society for Cardiovascular ... Orlando, FL, will offer clues to the fate of ... place in the treatment of coronary artery disease. ... treated at 30 medical centers in the United States ...
... SubbaRow, an Indian from Andhra Pradesh in the 1940s pioneered ... bring to humankind some lifesaving drugs widely used today. ... Indians would be familiar with, say he deserves a place ... his birth. ,SubbaRow, who headed research at US ...
... actress Kangana Ranaut but that hasn't stopped her from ... ,"I'm going to get married at the age of 26. So ... IANS. ,"He should be gentle, well-mannered and real... ... a doctor or a lecturer with a steady income. He should ...
... they are healthy as they are free from obesity . ... fat on the inside. ,Dr. Jimmy Bells team has ... does not mean one is not fat. ,The ... due to internal fat gathering around vital organs. ,The ...
... topic in the presidential elections in US. The issue is ... dont allow politicians to get away with glib talk. As ... the governments commitment to medicare, a group of cancer patients ... ,About 25 protesters wore shirts bearing the slogans "Cancer ...
Cached Medicine News:Health News:Florence Nightingales of India Honored by President 2Health News:The Forgotten Indian Medical Genius 2Health News:The Forgotten Indian Medical Genius 3Health News:Gentle, Real, Well-mannered - Kangana's Mr. Right 2Health News:Thin People may Be Internally Fat 2Health News:Cancer Patients Turn Their Backs on Canadian Health Minister 2
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
... Artis dBC is a flat detector ... architecture ideal for cardiological diagnostics and ... enables you to optimally adapt the ... pediatric, and electrophysiological applications with tableside ...
... TOPS is a support catheter which ... to angioplasty or stenting. The spiral catheter ... compatible with .014 to .018 steerable guidewires ... the occlusion is crossed, TOPS is withdrawn ...
The Thrombex PMT system is a self-contained, disposable clot-removal device that uses a motor-driven catheter and vacuum source to break up and remove thrombi from a hemodialysis graft....
Medicine Products: